Orexo Stakes Out $500M Market for New Opioid-Addiction Drug

Published July 14, 2013

Orexo stakes out 0M market for new opioid-addiction drug

Filed under: drug addiction symptoms

Orexo has high hopes for this treatment, estimating peak potential sales at $ 500 million. The company will now begin to compete with Reckitt Benckiser Group's Suboxone (also buprenorphine and naloxone) and Subutex. Reuters reports that those two drugs …
Read more on FierceBiotech

Number of drug addicts seeking treatment grows

Filed under: drug addiction symptoms

While this could mean that more people are aware of the benefits of seeking help for addiction, it could also indicate that more and more people are finding themselves addicted, said Dr Tarek Abdul Gawad, director of treatment and rehabilitation at the …
Read more on gulfnews.com